GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC91992 structure
    GC91992Calcium Influx Inducer Compound 634
    CAS: 882291-37-4
    Purity: >95.00%

    Calcium Influx Inducer Compound 634 es un inductor del influjo de calcio.

  • GC91993 structure
    GC91993Lavendamycin
    CAS: 81645-09-2
    Purity: >90.00%

    Lavendamycin es un metabolito bacterique se ha encontrado en S. lavendulae y tiene actividades antimicrobiy anticancerosas.

  • GC92001 structure
    GC92001PQA-18
    CAS: 1604678-82-1

    PQA-18 es un inhibidor de la quinasa 2 activada por p21 (PAK2; IC50 = 10 nM), un inmunosupres, y un derivado de Ppc-1.

  • GC92004 structure
    GC92004DPTIP (hydrochloride)
    CAS: 2361799-64-4
    Purity: >95.00%

    DPTIP (hydrochloride) es un inhibidor de la esfingomielinasa neutra 2 nSMase2; IC50 = 30 nM.

  • GC92014 structure
    GC92014PKN3 Inhibitor Compound 16
    CAS: 2361545-75-5
    Purity: >98.00%

    PKN3 Inhibitor Compound 16 es un inhibidor de la proteína quinasa de serina/treonina N3 (IC50 = 14 nM).

  • GC92018 structure
    GC92018N,N′-Diferuloylputrescine
    CAS: 42369-86-8
    Purity: >95.00%

    N,N′-Diferuloylputrescine es una poliamina que se ha encontrado en Z. mays y tiene diversas actividades biológicas.

  • GC92022 structure
    GC920224-hydroxy Nonenal Glutathione-d3
    Purity: >99.00%

    4-hydroxy Nonenal Glutathione-d3 (4-HNE-GSH-d3) está destinado para su uso como un estándar interno para la cuantide 4-HNE-GSH por GC- o LC-MS.

  • GC92023 structure
    GC92023PTX80
    CAS: 2376297-69-5
    Purity: >95.00%

    PTX80 es un antagonista de P62 (IC50 = 31,18 nM para el receptor humano).

  • GC92037 structure
    GC92037JQKD82 (hydrochloride)
    CAS: 2863676-87-1
    Purity: >98.00%

    JQKD82 (hydrochloride) es una forma de profármaco de KDM5-C49, un inhibide Jumonji AT-rich Interactive domain 1A (JARID1A), también conocido como lisina específica demetilasa 5A (KDM5A).

  • GC92040 structure
    GC92040SGC0946 (trifluoroacetate salt)
    Purity: >98.00%

    SGC0946 (trifluoroacetate salt) es un inhibide la metiltransferasa DOT1L (IC50 = 0.3 nM).

  • GC92043 structure
    GC920439(10)-Nitrooleate
    CAS: 1092676-99-7
    Purity: >95.00%

    9(10)-Nitrooleate es una mezcla de las moléculas de señalización lipíendde nitroalqueno 9-nitrooleato.

  • GC92044 structure
    GC92044H1L1A1B3
    CAS: 3097638-09-7
    Purity: >95.00%

    H1L1A1B3 es un lípido catiónico ionizable que se ha utilizado en combinación con otros lípidos en la formación de LNPs para la entrega de ARN circular (circRNA) in vitro e in vivo.

  • GC92066 structure
    GC92066RMC-6236
    CAS: 2765081-21-6
    Purity: >99.00%

    RMC-6236 es un inhibidor no covalente de RAS unido a GTP.

  • GC92067 structure
    GC92067Lipid N2-3L
    CAS: 2924606-55-1
    Purity: >95.00%

    Lipid N2-3L es un lípido catiónico ionizable (pKa = 8,99) que se ha utilizado en la generación de nanopartículas lipídicas supramoleculares (SMLNPs) encapsulando ARNm para su uso in vitro e in vivo.

  • GC92071 structure
    GC920716,6′-Trehalose Dioleate
    CAS: 338733-40-7
    Purity: >95.00%

    6,6′-Trehalose Dioleate (6,6 '-TDO) es un glicolípido que se ha utilizado en la generación de nanopartículas lipídicas (LNPs) para la entrega de ARNm in vitro e in vivo.

  • GC92072 structure
    GC92072YHS-12
    CAS: 2959463-68-2
    Purity: >95.00%

    YHS-12 es un lípido catiónico ionizable (pKa = 6.506) que se ha utilizado en la generación de nanopartículas lipídicas (LNPs) para la entrega de siRNA y ARNm in vitro e in vivo.

  • GC92074 structure
    GC920741,2,3-Trioleoyl Glycerol-d5
    CAS: 60892-83-3
    Purity: >99.00%

    1,2,3-Trioleoyl Glycerol-d5 está diseñado para usarse como un estándar interno para la cuantificación de 1,2,3-trioleglicerol por GC- o LC-MS.

  • GC92085 structure
    GC920854-O10b1
    Purity: >95.00%

    4-O10b1 es un lípido catiónico ionizable (pKa = 5.148) que se ha utilizado en la generación de nanopartículas lipídicas (LNPs) para la administración de siRNA in vitro e in vivo.

  • GC92088 structure
    GC92088GLP-1 (28-36) amide (trifluoroacetate salt)
    Purity: >98.00%

    1 GLP-1 (28-36) amide (trifluoroacetate salt) es un péptido y un metabolito activo del agonista endglp-1r GLP-1 (7-36) amida.

  • GC92099 structure
    GC92099MSG606 (trifluoroacetate salt)
    Purity: >95.00%

    MSG606 (trifluoroacetate salt) es un antagonista peptídico del receptor 1 de melanocortina (MC1R; IC50 = 17 nM para el receptor humano) y un derivado de la hormona estimulante de melanocitos (-MSH).

  • GC92112 structure
    GC92112Alsactide (trifluoroacetate salt)
    Purity: >95.00%

    Alsactide (trifluoroacetate salt) es un derivado peptídico de la hormona adrenocorticotrópica (ACTH), una hormona peptídica que se encuentra en el cerebro y que está involucrada en la respuesta biológica al estrés.

  • GC92127 structure
    GC92127Chlorotoxin (trifluoroacetate salt)
    Purity: >95.00%

    Chlorotoxin (trifluoroacetate salt) es un péptido aislado originalmente del veneno del escorpión L. quinquestriatus.

  • GC92130 structure
    GC92130Elsiglutide (acetate)
    Purity: >95.00%

    Elsiglutide (acetate) es un derivado peptídico del péptido tipo glucag2 GLP-2.

  • GD09670 structure
    GD096703,3-Dimethyl-1-butanol
    CAS: 624-95-3
    Purity: >99.50%

    3,3-Dimethyl-1-butanol es un inhibidor oral que suprime la producción de trimetilamina (TMA) por parte de los microorganismos e inhibe distintas trimetilaminas las microbianas